Quantum Biopharma Ltd. | WebDisclosure

Basculer en Français

10678	Companies
227831	Keywords
156266	Articles
120725	Press releases

Headlines Articles Press releases Quantum Biopharma Ltd.

Home
Companies
Quantum Biopharma Ltd.

PRESS RELEASE

published on 12/20/2024 at 15:15, 1 year 6 months ago

Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
Quantum BioPharma Ltd. purchases $1,000,000 Bitcoin and other cryptocurrencies, allows cryptocurrency transactions, emphasizing compliance and potential returns for shareholders

Bitcoin Compliance Investment Cryptocurrency Quantum BioPharma
BRIEF

published on 12/14/2024 at 01:05, 1 year 6 months ago

Quantum BioPharma conclut la première tranche de son offre

Première Tranche Biopharmacie Quantique Unités D'obligations Développement Du Capital Dollars Canadiens
BRIEF

published on 12/14/2024 at 01:05, 1 year 6 months ago

Quantum BioPharma Concludes Initial Tranche of Offering

First Tranche Capital Development Quantum BioPharma Canadian Dollars Debenture Units
PRESS RELEASE

published on 12/14/2024 at 01:00, 1 year 6 months ago

Quantum Biopharma Announces Closing of First Tranche
Quantum BioPharma closes initial tranche of offering, issuing 500 Debenture Units for $500,000. Proceeds for business development and working capital. Securities subject to statutory hold period

Working Capital Statutory Hold Period Quantum BioPharma Debenture Units Tranche Offering
BRIEF

published on 12/10/2024 at 13:35, 1 year 6 months ago

Quantum Biopharma avance dans l'essai clinique Lucid-MS

Recherche Biopharmaceutique Biopharmacie Quantique Examen De Sécurité Essai Lucid-MS Progrès Clinique
BRIEF

published on 12/10/2024 at 13:35, 1 year 6 months ago

Quantum Biopharma Moves Forward in Lucid-MS Clinical Trial

Biopharmaceutical Research Quantum BioPharma Lucid-MS Trial Clinical Advancement Safety Review
PRESS RELEASE

published on 12/10/2024 at 13:30, 1 year 6 months ago

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)
Quantum BioPharma announces approval to proceed with dosing of second cohort in Lucid-21-302 trial. Company focused on innovative treatments for neurodegenerative disorders

Drug Development Neurodegenerative Disorders Quantum BioPharma Lucid-21-302 Trial Safety Review Committee
BRIEF

published on 12/05/2024 at 13:35, 1 year 6 months ago

Quantum BioPharma Launches Private Placement for $5 Million

Private Placement Convertible Debenture Canadian Market Investment Offering Quantum BioPharma
BRIEF

published on 12/05/2024 at 13:35, 1 year 6 months ago

Quantum BioPharma lance un placement privé de 5 millions de dollars

Placement Privé Marché Canadien Obligation Convertible Biopharmacie Quantique Offre D'investissement
PRESS RELEASE

published on 12/05/2024 at 13:30, 1 year 6 months ago

Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million
Quantum BioPharma announces a non-brokered private placement offering of convertible debenture units. Proceeds for business development and working capital

Private Placement Working Capital Business Development Quantum BioPharma Debenture Units

Accesswire

Published on 07/03/2026 at 00:45, 3 hours 47 minutes ago

FireFox Gold Finalizes Finders Fees on Recent Offering
Published on 07/03/2026 at 00:05, 4 hours 27 minutes ago

Update to Tintina Mines Previous Announcement on June 2, 2026 of a C$91 Million Private Placement and Strategic Partnership with the Gignac Family and Sumitomo Corporation for the Development of the Domeyko Sulfuros Copper-Gold Project in Chile
Published on 07/03/2026 at 00:00, 4 hours 32 minutes ago

Redwood AI Added to CSE25 Index as One of the Largest Companies Listed on the Canadian Securities Exchange
Published on 07/02/2026 at 23:05, 5 hours 27 minutes ago

AI/ML Innovations Announces Completion of Share Issuance
Published on 07/02/2026 at 19:45, 8 hours 47 minutes ago

Infield Minerals Issues Shares for Kings Canyon Gold Property Option Payment

View all ACCESSWIRE

EQS Group

Published on 07/03/2026 at 02:05, 2 hours 26 minutes ago

JINRO, the World's No. 1 Soju Brand, Partners with V of BTS
Published on 07/02/2026 at 21:37, 6 hours 55 minutes ago

CEWE Completes Sale of Its Commercial Online-Print Division and Strengthens Its Focus on Profitable Growth in Photofinishing
Published on 07/02/2026 at 19:20, 9 hours 11 minutes ago

NNS acquires shares in OCI
Published on 07/02/2026 at 19:00, 9 hours 32 minutes ago

Infracore finalise l’acquisition des bâtiments du See-Spital à Horgen
Published on 07/02/2026 at 19:00, 9 hours 32 minutes ago

Infracore completes acquisition of See-Spital hospital buildings in Horgen

Les Echos

Published on 07/02/2026 at 18:33, 9 hours 58 minutes ago

Annonce des principales caractéristiques d'un projet d'offre publique de retrait et désignation expert financier
Published on 07/02/2026 at 18:28, 10 hours 3 minutes ago

Emova Group - Résultats 1er semestre 2025/26
Published on 07/02/2026 at 18:00, 10 hours 32 minutes ago

Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 30 juin 2026
Published on 07/02/2026 at 18:00, 10 hours 32 minutes ago

Outstanding shares and voting rights statement at 30 June 2026
Published on 07/02/2026 at 17:45, 10 hours 47 minutes ago

ENGIE va construire plus de 400 km de nouvelles lignes de transmission électrique au Pérou

View all LES ECHOS COMFI WIRE